Anju Bhardwaj is a Cardiology physician affiliated with Texas Medical Center. OpenAlex indexes 110 publications with 2,255 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
6400 Fannin St Ste 2500
Houston, TX 770301537
Telephone
713-704-4300Registry record last updated 6 Dec 2018.
Industry payments
14 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20252 payments
- CVRx, Inc.Program year20253 payments
- Impulse Dynamics (USA) Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
63.7%Beta blocker13.1%Metoprolol Succinate63%Carvedilol37%Part D≥29 patientsAldosterone antagonist (MRA)10.4%Spironolactone100%Part D≥36 patients+ 8 more classes in this area
Metabolism & gastrointestinal
14.2%SGLT2 inhibitor10%Farxiga61%Jardiance39%Part D≥23 patientsGLP-1 receptor agonist2.6%Ozempic100%Part D<11 patients+ 1 more class in this area
Blood & clotting
11.3%Factor Xa inhibitor5.6%Eliquis100%Part D<11 patientsVitamin K antagonist3.6%Warfarin Sodium100%Part D≥13 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Practical Guide on the Use of Induction Immunosuppression in Heart Transplantation
Circulation Heart Failure
2025 - Determinants of pulmonary hypertension in patients with end-stage kidney disease and arteriovenous access
Current Problems in Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
James Fleshman, MD
Texas Medical Center
Mark Zafereo, MD
Texas Medical Center
Mihail Chelu, MD, PhD
Texas Medical Center
Adan Rios, MD
Texas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”